Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients
Rhabdomyolysis - A Retrospective Study in Hospitalized Patients
- Analyze the various causes of breakdown of muscle fibers in hospitalized patients.
- Analyze the characteristics of these patients in Taiwan (including the drugs history, risk factors and the incidence of complications).
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Find the causes of breakdown of muscle fibers in hospitalized patients through medical record review.
- especially drug-related
- Find the risk factors of muscle fibers breakdown.
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Fe-Lin L Wu, MSCP, PhD
- Phone Number: 88389 +886-2-23123456
- Email: flwu@ntu.edu.tw
Study Contact Backup
- Name: Kwan-Dun Wu, MD, PhD
- Phone Number: 65014 +886-2-23123456
- Email: kdwu@ntuh.gov.tw
Study Locations
-
-
-
Taipei, Taiwan, 10051
- Recruiting
- National Taiwan University Hospital
-
Contact:
- Kwan-Dun Wu, MD, PhD
- Phone Number: 65014 886-2-23123456
- Email: kdwu@ntuh.gov.tw
-
Principal Investigator:
- Fe-Lin L Wu, MSCP, PhD
-
Sub-Investigator:
- Kwan-Dun Wu, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who admitted to The National Taiwan University Hospital during 2003/1/1~2008/12/31 with the following discharge diagnosis: myoglobinuria, rhabdomyolysis, myopathy, toxic myopathy, malignant hyperthermia, neuroleptic malignant syndrome, polymyositis, myalgia and had acute neuromuscular illness presentations and serum creatinine kinase (CK) more than 5 times the upper limit of normal (male > 900 IU/L; female > 835 IU/L).
Exclusion Criteria:
- Patients with recent myocardial infarction or stroke, unless clinical history, examination, or electromyography showed a concomitant myopathy.
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Fe-Lin L Wu, MSCP, PhD, Graduate Institute of Clinical Pharmacy, National Taiwan University
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Chemically-Induced Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Kidney Diseases
- Urologic Diseases
- Musculoskeletal Diseases
- Neuromuscular Diseases
- Basal Ganglia Diseases
- Poisoning
- Neurotoxicity Syndromes
- Renal Insufficiency
- Acute Kidney Injury
- Muscular Diseases
- Rhabdomyolysis
- Neuroleptic Malignant Syndrome
Other Study ID Numbers
Other Study ID Numbers
- 200911033R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.